Continuous Assessment of Levodopa Response in Parkinson's Disease Using Wearable Motion Sensors
- 25 April 2017
- journal article
- research article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 65 (1), 159-164
- https://doi.org/10.1109/tbme.2017.2697764
Abstract
Objective: Fluctuations in response to levodopa in Parkinson's disease (PD) are difficult to treat as tools to monitor temporal patterns of symptoms are hampered by several challenges. The objective was to use wearable sensors to quantify the dose response of tremor, bradykinesia, and dyskinesia in individuals with PD. Methods: Thirteen individuals with PD and fluctuating motor benefit were instrumented with wrist and ankle motion sensors and recorded by video. Kinematic data were recorded as subjects completed a series of activities in a simulated home environment through transition from off to on medication. Subjects were evaluated using the unified Parkinson disease rating scale motor exam (UPDRS-III) at the start and end of data collection. Algorithms were applied to the kinematic data to score tremor, bradykinesia, and dyskinesia. A blinded clinician rated severity observed on video. Accuracy of algorithms was evaluated by comparing scores with clinician ratings using a receiver operating characteristic (ROC) analysis. Results: Algorithm scores for tremor, bradykinesia, and dyskinesia agreed with clinician ratings of video recordings (ROC area > 0.8). Summary metrics extracted from time intervals before and after taking medication provided quantitative measures of therapeutic response (p <; 0.01). Radar charts provided intuitive visualization, with graphical features correlated with UPDRS-III scores (R = 0.81). Conclusion: A system with wrist and ankle motion sensors can provide accurate measures of tremor, bradykinesia, and dyskinesia as patients complete routine activities. Significance: This technology could provide insight on motor fluctuations in the context of daily life to guide clinical management and aid in development of new therapies.Keywords
Funding Information
- National Institute on Aging
- National Institutes of Health (5R44AG044293)
This publication has 29 references indexed in Scilit:
- Body-Worn Sensors in Parkinson's Disease: Evaluating Their Acceptability to PatientsTelemedicine and e-Health, 2016
- Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's diseaseMovement Disorders, 2015
- An Objective Fluctuation Score for Parkinson's DiseasePLOS ONE, 2015
- Automatic and Objective Assessment of Alternating Tapping Performance in Parkinson’s DiseaseSensors, 2013
- Continuous in-home monitoring of essential tremorParkinsonism & Related Disorders, 2013
- Quantitative analysis of gait and balance response to deep brain stimulation in Parkinson's diseaseGait & Posture, 2013
- Objective Motion Sensor Assessment Highly Correlated with Scores of Global Levodopa-Induced Dyskinesia in Parkinson's DiseaseJournal of Parkinson's Disease, 2013
- Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical TrialsCNS Neuroscience & Therapeutics, 2011
- The modified bradykinesia rating scale for Parkinson's disease: Reliability and comparison with kinematic measuresMovement Disorders, 2011
- Ambulatory motor assessment in Parkinson's diseaseMovement Disorders, 2005